APREPITANT 125-80-80 MG PACK
For 1 unit (EA)
Pharmacies pay
$85.02 filed
1 × $85.017 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$96.14 filed
1 × $96.14177 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
1.1× estimated
Medicare paid 1.1× what pharmacies pay.
Part D averages every strength and form sold under “Aprepitant” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$102.77 estimated
$85.02 + $12.75 (15%) + $5.00 fee per fill = $102.77
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
APREPITANT 125-80-80 MG PACK is how the CMS NADAC file names this product. The FDA NDC Directory lists it as aprepitant.
FDA gives its dosage form as kit.
FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Sandoz Inc, Torrent Pharmaceuticals Limited and BluePoint Laboratories.
FDA lists no Established Pharmacologic Class for it.
The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $85.02 for 1 unit (EA) (1 × $85.017 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · NADAC explanation codes
All 4 NDCs
- 00781-4063-36 · Sandoz Inc · $85.017 per EA · eff. 2026-09-23 filed
- 13668-0594-87 · Torrent Pharmaceuticals Limited · $85.017 per EA · eff. 2026-09-23 filed
- 68001-0669-15 · BluePoint Laboratories · $85.017 per EA · eff. 2026-09-23 filed
- 68462-0112-33 · Glenmark Pharmaceuticals Inc., USA · $85.017 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
4 other products in the NADAC file share the FDA nonproprietary name aprepitant with APREPITANT 125-80-80 MG PACK.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| APREPITANT 40 MG CAPSULE | $46.42062 per EA filed | $96.14177 per EA filed |
| APREPITANT 80 MG CAPSULE | $76.35243 per EA filed | $96.14177 per EA filed |
| APREPITANT 125 MG CAPSULE | $114.04399 per EA filed | $96.14177 per EA filed |
| APREPITANT 125-80-80 MG PACK this page | $85.017 per EA filed | $96.14177 per EA filed |
| EMEND 125 MG POWDER PACKET | $327.384 per EA filed | $62.775 per EA derived |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
What Medicare paid
Medicare Part D paid $96.14 for 1 unit (EA), at an average of $96.14177 per EA in 2024 (2024-01-01 to 2024-12-31) for “Aprepitant”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 12,502 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 unit (EA)? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for APREPITANT 125-80-80 MG PACK labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Aprepitant / Aprepitant: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
- Why does this page start at 1 unit (EA)?
- NADAC prices this product per EA, and the FDA NDC Directory lists its 4 NDCs as dosage form “KIT” with no route. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. NADAC’s EA for it may be the whole kit or one item in it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.